isoproterenol has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, JJ; Chen, LZ; Chen, X; Gao, Z; Gong, YS; Huang, WJ; Wang, LX; Zhang, HQ; Zhou, H; Zhou, X | 1 |
1 other study(ies) available for isoproterenol and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester
Article | Year |
---|---|
Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
Topics: Animals; Cardiomyopathies; Cell Movement; Cells, Cultured; Collagen; Dipeptides; Disease Models, Animal; Endothelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Isoproterenol; Male; Myocardium; Neovascularization, Physiologic; Rats, Sprague-Dawley; Receptor, Notch1; Relaxin; Signal Transduction; Ventricular Function, Left | 2015 |